LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 42.67 | 771.67 | 4845 | 5155 | 0.9397 | 0.9551 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 42.67 | 771.67 | 4697 | 5155 | 0.9110 | 0.9331 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.89 | 771.67 | 5468 | 5541 | 0.9867 | 0.9906 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.89 | 771.67 | 6379 | 5541 | 1.1511 | 1.1015 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.89 | 771.67 | 5209 | 5541 | 0.9400 | 0.9570 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.89 | 771.67 | 5063 | 5541 | 0.9137 | 0.9375 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.11 | 771.67 | 5808 | 5941 | 0.9775 | 0.9846 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.11 | 771.67 | 6963 | 5941 | 1.1719 | 1.1107 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.11 | 771.67 | 5629 | 5941 | 0.9474 | 0.9636 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.11 | 771.67 | 5454 | 5941 | 0.9180 | 0.9427 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.33 | 771.67 | 6141 | 6392 | 0.9606 | 0.9738 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.33 | 771.67 | 7365 | 6392 | 1.1521 | 1.0950 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.33 | 771.67 | 5993 | 6392 | 0.9375 | 0.9581 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.33 | 771.67 | 5866 | 6392 | 0.9176 | 0.9444 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.55 | 771.67 | 6621 | 6829 | 0.9694 | 0.9804 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.55 | 771.67 | 8079 | 6829 | 1.1829 | 1.1097 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.55 | 771.67 | 6239 | 6829 | 0.9135 | 0.9433 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.55 | 771.67 | 6357 | 6829 | 0.9308 | 0.9549 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 771.67 | 7075 | 7256 | 0.9750 | 0.9844 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 771.67 | 8485 | 7256 | 1.1693 | 1.0991 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 771.67 | 6647 | 7256 | 0.9160 | 0.9465 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 53.77 | 771.67 | 6759 | 7256 | 0.9315 | 0.9566 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.99 | 771.67 | 7623 | 7690 | 0.9913 | 0.9947 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.99 | 771.67 | 8940 | 7690 | 1.1625 | 1.0929 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.99 | 771.67 | 6996 | 7690 | 0.9097 | 0.9438 | MN20160304_L01 | N10 |